Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2003
09/03/2003EP1339855A2 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
09/03/2003EP1339854A2 Lipid metabolism enzymes
09/03/2003EP1339851A2 Basb221 polypeptides and polynucleotides encoding basb221 polypeptides
09/03/2003EP1339850A2 A novel cocoa albumin and its use in the production of cocoa and chocolate flavour
09/03/2003EP1339847A2 Transforming growth factor-beta-related molecules and uses thereof
09/03/2003EP1339846A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339845A2 Adipocyte complemented related protein zacrp3x2
09/03/2003EP1339844A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339839A2 Human transporter family members and uses thereof
09/03/2003EP1339836A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
09/03/2003EP1339834A2 Enzymes
09/03/2003EP1339753A2 Percarboxylated polysaccharides, and a process for their preparation
09/03/2003EP1339751A2 Recombinant antibody fragments as autoantibody antagonists
09/03/2003EP1339748A2 G-protein coupled receptors
09/03/2003EP1339746A2 Binding polypeptides for b lymphocyte stimulator protein (blys)
09/03/2003EP1339744A2 Production of recombinant bmp-2
09/03/2003EP1339742A2 Human protein differentially expressed in alzheimer's disease's brain
09/03/2003EP1339739A2 Methods and compositions involved in groucho-mediated differentiation
09/03/2003EP1339738A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
09/03/2003EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus
09/03/2003EP1339736A2 Oncolytic virus
09/03/2003EP1339735A1 Method for preparing tryptophan rich peptides
09/03/2003EP1339440A1 An implantable or insertable therapeutic agent delivery device
09/03/2003EP1339438A2 Methods for preventing transplant rejection in the eye
09/03/2003EP1339433A2 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma
09/03/2003EP1339431A1 Improved oral delivery of peptides using enzyme-cleavable membrane translocators
09/03/2003EP1339425A2 Vaccine composition containing transforming growth factor alpha
09/03/2003EP1339424A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
09/03/2003EP1339422A2 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
09/03/2003EP1339421A1 Cosmetic and/or dermopharmaceutical preparations containing native proteins from the plant argania spinosa
09/03/2003EP1339391A1 Synthesis of small particles
09/03/2003EP1339388A1 Particulate inhalation carrier
09/03/2003EP1339387A2 Stable, aerosolizable suspensions of proteins (e.g. insulin, dnase) in ethanol
09/03/2003EP1339378A1 Use of cyclosporin a 7-thioamide derivatives for hair growth
09/03/2003EP1339377A1 Use of cyclosporin 7-thioamide derivatives for hair growth
09/03/2003EP1339349A2 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants
09/03/2003EP1339294A1 Nutritional composition for an immune condition
09/03/2003EP1196414B1 Prodrugs of carbamate inhibitors of impdh
09/03/2003EP1183046B1 Aminotetralin derivative for the therapy of cardiovascular diseases
09/03/2003EP1095038B1 Antagonists of gonadotropin releasing hormone
09/03/2003EP1083915A4 Compositions and methods for enhancing protein anabolism and detoxification
09/03/2003EP0973391A4 Endoderm, cardiac and neural inducing factors
09/03/2003EP0927195B1 Process for producing a plasma protein-containing medicament
09/03/2003EP0925070B1 Antifungal combination therapy
09/03/2003EP0914614B1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrPsc
09/03/2003EP0857210B1 Therapeutic antiangiogenic compositions and methods
09/03/2003EP0833670B1 Vaccine against rotavirus infection comprising peptides of viral enterotoxin nsp4
09/03/2003EP0765172B1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
09/03/2003EP0763116B1 Recombinant viruses, preparation and use thereof in gene therapy
09/03/2003EP0757994B1 Tcf mutant
09/03/2003EP0751780B1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods
09/03/2003EP0651646B1 Therapeutic conjugates of toxins and drugs
09/03/2003EP0607297B1 Hormone analogs with multiple ctp extensions
09/03/2003CN1440459A Expression system
09/03/2003CN1440423A Immunoadhesin for the prevention of rhinovirus infection
09/03/2003CN1440422A Novel gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same
09/03/2003CN1440420A Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
09/03/2003CN1440396A Colchinol derivatives as angiogenesis inhibitors
09/03/2003CN1440388A Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same
09/03/2003CN1440387A Alpha crystalline form of perindopril tert-butyllamine salt
09/03/2003CN1440386A Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same
09/03/2003CN1440298A Medical aerosol formulation
09/03/2003CN1440294A Medical components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
09/03/2003CN1440283A Combination of organic compounds
09/03/2003CN1440282A Improved thyroid hormone formulations
09/03/2003CN1440277A Particular carrier with active components with improved oral absorbing performance
09/03/2003CN1439663A Method for extracting and purifying cartilage style proteoglycan
09/03/2003CN1439427A Use of gene recombination human lysozyme against drug resistant bacteria in preparation of medicine
09/03/2003CN1439426A Medicine composition and preparation and use thereof
09/03/2003CN1439425A Anticancer medicine made from phytohemagglutinin
09/03/2003CN1439424A Anti-SARS virus transfer factor preparation method
09/03/2003CN1439299A Intestinal absorbing fully nutrient emulsion for phymatostio patient
09/03/2003CN1439298A Cellulosefree intestinal absorbing nutrient emulsion and its preparing method
09/03/2003CN1120173C Antitumor substance extracted from Grifola
09/03/2003CN1120019C Insulin preparations containing NaCl
09/02/2003US6614831 Mounting arrangement for auxiliary burner or lance
09/02/2003US6613957 Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic non-human mammals
09/02/2003US6613892 Continuously expressing an inserted heterologous gene while remaining latent
09/02/2003US6613891 Polynucleotides that encode bovine inhibin
09/02/2003US6613890 Analogues of Kunitz protease inhibitor domain of amyloid precursor protein bind to and inhibit activity of serine proteases including kallikrein, plasmin, and coagulation factors VIIa, IXa, Xa, XIa, and XIIa; for treating blood loss
09/02/2003US6613887 Human ependymin-like protein
09/02/2003US6613883 Screening assays for compounds that cause apoptosis and related compounds
09/02/2003US6613882 Use for intracellular transport and membrane presentation of certain epitopes
09/02/2003US6613881 Isolated polypeptide of given amino acid sequence; can use in vaccines
09/02/2003US6613880 Pipecolic acid derivatives of proline threonine amides useful for the treatment of rheumatoid arthritis
09/02/2003US6613879 FAP-activated anti-tumour compounds
09/02/2003US6613878 PCNA binding substance
09/02/2003US6613874 Melanocortin receptor ligands
09/02/2003US6613873 Covalently bound to a polyamide backbone; given formula; exhibit increased sequence specificity and binding affinity; resistant to enzyme degradation
09/02/2003US6613872 Compounds for immunotherapy of prostate cancer and methods for their use
09/02/2003US6613802 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/02/2003US6613788 Transdermal patch to systemically deliver effective dose of histamine comprising histamine and controlled release preparation which releases drug over period of time sufficient to obtain stable elevated levels in circulating blood
09/02/2003US6613750 Inhibiting growth of a tumor cell by introducing to the cell an effective amount of p19ARF protein or mimetic thereof, and p53
09/02/2003US6613746 Cell adhesion proteins having cells with glycoprotein antibodies and carbohydrate determinants used to interfere with binding FC receptor and as complement inhibitors; antiinflammatory agents
09/02/2003US6613745 Therapeutic molecules derived from snake venom
09/02/2003US6613744 BMP-6 proteins
09/02/2003US6613742 Chemokine-derived synthetic peptides
09/02/2003US6613741 Method for treating aseptic SIRS in humans and other animals
09/02/2003US6613740 Activity dependent neurotrophic factor III (ADNF III)
09/02/2003US6613739 Immunosuppressants
1 ... 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 ... 3163